Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Daily Journal
DJCO
$809M
| $175K | ﹤0.01% |
613
+287
| +88% | +$83.2K |
|
3752
Vertex
VERX
$2.09B
| $175K | ﹤0.01% |
8,440
+6,770
| +405% | +$104K |
|
3753
Arbutus Biopharma
ABUS
$857M
| $174K | ﹤0.01% |
57,558
+27,054
| +89% | +$76.3K |
|
3754
Centrus Energy
LEU
$3.48B
| $174K | ﹤0.01% |
5,395
+2,536
| +89% | +$97.4K |
|
3755
Mistras Group
MG
$484M
| $174K | ﹤0.01% |
25,617
+2,881
| +13% | +$15.8K |
|
3756
Beam Global
BEEM
$23.3M
| $174K | ﹤0.01% |
+10,906
| New | +$180K |
|
|
ASLN
3757
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $173K | ﹤0.01% |
7,500
-282
| -4% | -$7.63K |
|
3758
SelectQuote
SLQT
$132M
| $172K | ﹤0.01% |
79,484
+43,131
| +119% | +$69.6K |
|
3759
RE/MAX Holdings
RMAX
$193M
| $172K | ﹤0.01% |
9,190
+491
| +6% | +$9.77K |
|
|
PTRA
3760
DELISTED
Proterra Inc. Common Stock
PTRA
| $172K | ﹤0.01% |
113,163
+53,125
| +88% | +$200K |
|
|
KIO
3761
KKR Income Opportunities Fund
KIO
$451M
| $172K | ﹤0.01% |
+14,056
| New | +$159K |
|
3762
Hingham Institution for Saving
HIFS
$627M
| $172K | ﹤0.01% |
735
+342
| +87% | +$93.8K |
|
3763
Genie Energy
GNE
$367M
| $171K | ﹤0.01% |
12,396
+2,160
| +21% | +$24.6K |
|
3764
Inogen
INGN
$175M
| $171K | ﹤0.01% |
13,697
+2,518
| +23% | +$48.2K |
|
3765
CALL
General Mills
GIS
$19.1B
| $171K | ﹤0.01% |
2,000
-50,000
| -96% | -$3.99M |
|
3766
Security National Financial
SNFCA
$244M
| $171K | ﹤0.01% |
33,335
| – | – |
|
3767
Bionano Genomics
BNGO
$12.3M
| $171K | ﹤0.01% |
256
+119
| +87% | +$106K |
|
3768
HCI Group
HCI
$2.23B
| $170K | ﹤0.01% |
3,168
-1,822
| -37% | -$91.6K |
|
3769
Senseonics Holdings Inc
SENS
$263M
| $170K | ﹤0.01% |
11,951
+5,602
| +88% | +$113K |
|
3770
Nano X Imaging
NNOX
$68.2M
| $169K | ﹤0.01% |
29,339
+17,029
| +138% | +$130K |
|
3771
Carter Bankshares
CARE
$766M
| $169K | ﹤0.01% |
12,044
+5,644
| +88% | +$91K |
|
|
LBC
3772
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $168K | ﹤0.01% |
17,720
+3,441
| +24% | +$38.1K |
|
|
GAMB
3773
DELISTED
Gambling.com
GAMB
| $168K | ﹤0.01% |
16,936
+10,854
| +178% | +$104K |
|
3774
Liquidia Corp
LQDA
$7.48B
| $167K | ﹤0.01% |
24,220
+11,320
| +88% | +$77.3K |
|
3775
Erasca
ERAS
$6.3B
| $167K | ﹤0.01% |
55,598
-104,163
| -65% | -$379K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.